<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: The influence of <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> on the performance of glomerular filtration rate (GFR) estimating equations remains to be determined </plain></SENT>
<SENT sid="1" pm="."><plain>We compared the performance of <z:chebi fb="0" ids="16737">creatinine</z:chebi>-based GFR with cystatin C-based GFR in patients with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> according to glycaemic status </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: In a cross-sectional study of 210 patients with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, we staged glycaemic status by HbA(1c) tertiles [HbA(1c) ≤ 75 mmol/mol (9.0%) (n = 70), HbA(1c) 76-95 mmol/mol (9.1-10.8%) (n = 70), HbA(1c) &gt;95 mmol/mol (10.8%) (n = 70)] and measured GFR </plain></SENT>
<SENT sid="3" pm="."><plain>Isotopic GFR was measured using renal dynamic imaging with (99m) Tc-diethylene-<z:chebi fb="1" ids="38751">triamine</z:chebi>-penta-<z:chebi fb="22" ids="15366">acetic acid</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Estimated GFR (eGFR) was measured using <z:chebi fb="0" ids="16737">creatinine</z:chebi>-based formulae (Cockcroft-Gault-eGFR, the Modification of Diet in <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">Renal Disease</z:e> equation-eGFR and the <z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">Kidney Disease</z:e> Epidemiology Collaboration formula-eGFR) and a cystatin C-based formula (cystatin C-eGFR) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The isotopic GFR of <z:hpo ids='HP_0000001'>all</z:hpo> patients was 93.1 ± 34.1 ml min(-1) 1.73 m(-2) </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> methods for estimating GFR underestimated isotopic GFR [Cockcroft-Gault-eGFR (68.8 ± 38.6 ml min(-1) 1.73 m(-2) ) (P &lt; 0.05), Modification of Diet in <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">Renal Disease</z:e>-eGFR (74.8 ± 31.3 ml min(-1) 1.73 m(-2) ) (P &lt; 0.05), <z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">Kidney Disease</z:e> Epidemiology Collaboration-eGFR (72.9 ± 26.6 ml min(-1) 1.73 m(-2)) (P &lt; 0.05) and cystatin C-eGFR (83.5 ± 33.2 ml min(-1) 1.73 m(-2)) (P &lt; 0.05)] </plain></SENT>
<SENT sid="7" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> patient groups, cystatin C-eGFR was less biased and more accurate than the <z:chebi fb="0" ids="16737">creatinine</z:chebi>-based formulae, especially in the group with HbA(1c) &gt; 95 mmol/mol (10.8%) where there was no difference between cystatin C-eGFR and isotopic GFR </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Performance of cystatin C-eGFR was superior to <z:chebi fb="0" ids="16737">creatinine</z:chebi>-based GFR in patients with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> with HbA(1c) &gt;95 mmol/mol (10.8%) </plain></SENT>
</text></document>